Action of δ-9-tetrahydrocannabinol on GABA(A) receptor-mediated responses in a grease-gap recording preparation of the rat hippocampal slice

Neuropharmacology

Volumn 36, Issue 10, 1997, Pages 1387-1392

  Coull, Moyra A ^a   Johnston, Andrew T ^a   Pertwee, Roger G ^a   Davies, Stephen N ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

9 tetrahydrocannabinol; Baclofen; Cannabinoids; GABA; Muscimol; Uptake

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; BACLOFEN; MUSCIMOL; TETRAHYDROCANNABINOL DERIVATIVE;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CANNABIS ADDICTION; DRUG EFFECT; FEMALE; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIEMETICS; BACLOFEN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GABA AGONISTS; HIPPOCAMPUS; MUSCIMOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; TETRAHYDROCANNABINOL;

EID: 0030782054     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00110-X     Document Type: Article

References (31)

1. Banerjee S. P., Snyder S. H. and Mechoulam R. (1975) Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes. Journal of Pharmacology and Experimental Therapeutics 194: 74-81.
2. Caulfield M. P. and Brown D. A. (1992) Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin sensitive mechanism. British Journal of Pharmacology 106: 231-232.
3. Devane W. A., Dysarz F. A., Johnson M. R., Melvin L. S. and Hewlett A. C. (1988) Determination and characterization of a cannabonoid receptor in rat brain. Molecular Pharmacology 34: 605-613.
4. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A. and Mechoulam R. (1992) Isolation and structure of a brain constituent which binds to the cannabinoid receptor. Science 258: 1946-1949.
5. Dutar P. and Nicoll R. A. (1988) A physiological role for GABAb receptors in the central nervous system. Nature 332: 156-158.
6. Harrison N. L. and Simmonds M. A. (1985) Quantitative studies on some antagonists of N-methyl-D-aspartate in slices of rat cerebral cortex. British Journal of Pharmacology 84: 381-391.
7. Herkenham M., Lynn A. B., Johnson M. R., Melvin L. S., De Costa B. R. and Rice K. C. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. Journal of Neuroscience III: 563-583.
8. Hershkowitz M., Goldman R. and Raz A. (1977) Effects of cannabinoids on neurotransmitter uptake, ATPase activity and morphology of mouse brain synaptosomes. Biochemical Pharmacology 26: 1327-1331.
9. A-receptor complex in rat brain during chronic elevation of GABA by ethanolamine O-sulphate. British Journal of Pharmacology 91: 617-625.
10. Liu Q. -R., Lopez-Corcuera B., Mandiyan S., Nelson H. and Nelson N. (1993) Molecular characterisation of four pharmacologically distinct γ-aminobutyric acid transporters in mouse brain. Journal of Biological Chemistry 268: 2106-2112.
11. Mackie K. and Hille B. (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proceedings of the National Academy of Sciences U.S.A. 89: 3825-3829.
12. Mackie K., Lai Y., Westenbroek R. and Mitchell R. (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. Journal of Neuroscience 15: 6552-6561.
13. Maneuf Y. P. and Brotchie J. M. (1995) Modulation of gamma-aminobutyric acid (GABA) uptake by cannbinoids and protein kinases in the globus pallidus. Brain Research Association Abstracts 12: 25.5.
14. Martin D., Bowe M. A. and Nadler J. V. (1989) A grease-gap method for studying the excitatory ammo acid pharmacology of CA1 hippocampal pyramidal cells. Journal of Neuroscience Methods 29: 107-114.
15. Martin D. and Nadler J. V. (1991) Grease-gap methods for studying pharmacology of excitatory amino acids on central nervous system neurons. Methods in Neuroscience 4: 349-364.
16. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C. and Bonner T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
17. Pertwee, R. G. (1990) The central neuropharmacology of psychotropic cannabinoids. In Psychotropic Drugs of Abuse, ed. D. J. K. Balfour, pp. 355-429. Pergamon Press, New York.
18. Pertwee, R. G. (1992) In vivo interactions between psychotropic cannabinoids and other drugs involving central and peripheral neurochemical mediators. In Marijuana/Cannabinoids, eds. L. Murphy and A. Bartke, pp. 165-218. CRC Press, Boca Raton.
19. Pertwee R. G. (1993) The evidence for the existence of cannabinoid receptors. General Pharmacology 24: 811-824.
20. Pertwee R. G. and Greentree S. G. (1988) Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide. Neuropharmacology 27: 485-491.
21. Pertwee R. G., Greentree S. G. and Swift P. A. (1988) Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice. Neuropharmacology 27: 1265-1270.
22. Pertwee R. G. and Griffin G. (1995) A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens. European Journal of Pharmacology 272: 67-72.
23. Pertwee R. G., Griffin G., Fernando S., Li X., Hill A. and Makriyannis A. (1995) AM630, a competitive cannabinoid receptor antagonist. Life Sciences 56: 1949-1955.
24. Pertwee R. G. and Wickens A. P. (1991) Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids. Neuropharmacology 30: 237-244.
25. Revuelta A. V., Cheney D. L., Wood P. L. and Costa E. (1979) GABAergic mediation of the inhibition of hippocampal acetylcholine turnover rate elicited by delta-9-tetrahydrocannabinol. Neuropharmacology 18: 525-530.
26. Rinaldi-Carmona M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Néliat G., Caput D., Ferrara P., Soubrié P., Breliere J. C. and Le Fur G. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letters 350: 240-244.
27. Schwartzkroin P. A. and Knowles W. D. (1983) Local interactions in the hippocampus. Trends in Neurosciences 6: 88-92.
28. Vardaris R. M., Weisz D. J. and Teyler T. J. (1977) Delta-9-tetrahydrocannabinol and the hippocampus: effects on CA1 field potentials in rats. Brain Research Bulletin 2: 181-187.
29. Weisz D. J., Gunnell D. L., Teyler T. J. and Vardaris R. M. (1982) Changes in hippocampal CA1 population spikes following administration of delta-9-THC. Brain Research Bulletin 8: 155-162.
30. Wickens A. P. and Pertwee R. G. (1993) Delta 9-tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats. European Journal of Pharmacology 250: 205-208.
31. Wickens A. P. and Pertwee R. G. (1995) Effect of delta-9-tetrahydrocannabinol on circling in rats induced by intranigral muscimol administration. European Journal of Pharmacology 282: 251-254.